- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic Syndromes
Total 34070 results
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
BioLineRx, Ltd.CompletedAplastic Anemia | Hypoplastic Myelodysplastic SyndromeUnited States
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingLower-risk MyelodysplasticJapan
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
Josep Carreras Leukaemia Research InstituteCelgeneRecruitingMyelodysplastic SyndromesSpain
-
University of Erlangen-Nürnberg Medical SchoolNovartis PharmaceuticalsTerminated
-
Centre Hospitalier Universitaire, AmiensUnknownMyelodysplastic SyndromesFrance
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; YUKIGUNI COMPANYCompletedMyelodysplastic SyndromeUnited States
-
Peking Union Medical College HospitalNot yet recruitingMyelodysplastic SyndromesChina
-
McMaster UniversityCBSRecruitingMyelodysplastic SyndromeCanada
-
Stanford UniversityNotable Labs Inc.Active, not recruitingMyelodysplastic SyndromesUnited States
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
University of WashingtonCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Van Andel Research InstituteActive, not recruitingChronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Myelodysplastic SyndromeUnited States
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
National Cancer Institute (NCI)TerminatedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | de Novo Myelodysplastic SyndromesUnited States
-
Peking Union Medical College HospitalNot yet recruitingMyelodysplastic Syndromes
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitation
-
CelgeneCompleted
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Sanquin Research & Blood Bank DivisionsNetherlands: Ministry of Health, Welfare and SportsWithdrawnMyelodysplastic SyndromesNetherlands
-
City of Hope Medical CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Adult Acute Myeloid Leukemia | de Novo Myelodysplastic SyndromesUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownInfection | Risk Factors | Myelodysplastic Syndrome (MDS) | IPSS High RiskFrance
-
Minovia Therapeutics Ltd.RecruitingMyelodysplastic SyndromesIsrael
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic SyndromesUnited States
-
Anhui Provincial HospitalRecruitingMyelodysplastic SyndromesChina
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
AkesoRecruitingMyelodysplastic SyndromeChina
-
University Hospital, ToulouseRecruitingMyelodysplastic SyndromesFrance
-
Peking University People's HospitalRecruiting
-
Institut Paoli-CalmettesRecruiting
-
Yonsei UniversityRecruitingMyelodysplastic SyndromeKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Astex Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesSpain, United States, Belgium, Canada, Germany, Italy
-
Astex Pharmaceuticals, Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
Shanghai Antengene Corporation LimitedTerminated
-
Washington University School of MedicineJazz PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States